Neurogene stock surges 30% on FDA breakthrough therapy status
Baldwin Group reports 7% organic revenue growth in 2025
Monster Beverage earnings beat by $0.03, revenue topped estimates
RBC Capital raises BeOne Medicines stock price target to $425
Trump and Mamdani meet for second time, discuss housing, detention of student
Newsletter
Subscribe to get the latest news, offers and special announcements.


